Tomaini D, Cataldi M, Ferrario D, Giudici C
Servizio di anatomia ed istologia patologica e di citodiagnostica, Ospedale S. Anna di Como.
Pathologica. 1992 Mar-Apr;84(1090):165-70.
A retrospective study of DNA content in 38 medium-rectal adenocarcinomas (a rectal part between 8 and 12 cm. from anus) was performed using flow cytometry in order to find probable correlations among ploidy, grading, staging and survival in patients who had undergone a surgical operation from January 1975 to December 1989. At the beginning of the work, 21 patients were alive and 17 were dead. Histologically 15 carcinomas (39.4%) were G1, 22 (57.8%) were G2 and only 1 (2.6%) was G3. Moreover 1 case (2.6%) was pT1, 7 (18.4%) were pT2 and 30 (78.9%) were pT3. 11 adenocarcinomas (29%) were euploid and 27 (71%) were aneuploid. These percentages agree with literature data. 11 of dead patients (64.7%) had aneuploid neoplasias and 6 (35.3%) diploid; 16 of alive patients (72.2%) had aneuploid carcinomas and 5 (23.8%) diploid. The difference of survival between aneuploid and diploid carcinomas isn't statistically significative (X2 = 0.168 ns). No correlation was found among aneuploidy, grading and staging, probably on account of small number of analyzed cases, owing to particular and little rectal part included in the study. Likely, having a larger case number we'll be able to obtain more incisive informations from this type of analysis in the next future.
为了找出1975年1月至1989年12月期间接受手术治疗的患者的倍性、分级、分期和生存率之间可能存在的相关性,我们采用流式细胞术对38例中直肠腺癌(距肛门8至12厘米的直肠部分)的DNA含量进行了回顾性研究。研究开始时,21例患者存活,17例死亡。组织学上,15例癌(39.4%)为G1级,22例(57.8%)为G2级,仅1例(2.6%)为G3级。此外,1例(2.6%)为pT1期,7例(18.4%)为pT2期,30例(78.9%)为pT3期。11例腺癌(29%)为整倍体,27例(71%)为非整倍体。这些百分比与文献数据一致。死亡患者中有11例(64.7%)患有非整倍体肿瘤,6例(35.3%)为二倍体;存活患者中有16例(72.2%)患有非整倍体癌,5例(23.8%)为二倍体。非整倍体癌和二倍体癌之间的生存率差异无统计学意义(X2 = 0.168,无显著性)。在非整倍体、分级和分期之间未发现相关性,可能是由于研究中纳入的直肠部分特殊且病例数较少。很可能,未来我们有了更多病例数后,能够从这类分析中获得更确切的信息。